Human umbilical cord blood myeloid progenitor cells are relatively chemoresistant: A potential model for autologous transplantations in HIV- infected newborns

American Journal of Hematology

Volumn 56, Issue 3, 1997, Pages 161-167

  Toren, Amos ^a,c   Einat, Michal ^b   Fabian, Ina ^b   Nagler, Arnon ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

ARA C; Colony forming units; Eilatin; Human progenitor cells (HPC); Human umbilical cord blood (HUCB); Interferon (IFN ); Liquid culture; Self renewal

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CYTARABINE; INTERLEUKIN 3; ZIDOVUDINE;

ARTICLE; AUTOTRANSPLANTATION; BONE MARROW CELL; CELL RENEWAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEWBORN INFECTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION;

ANTIVIRAL AGENTS; BONE MARROW CELLS; CELL DIVISION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CYTARABINE; DRUG RESISTANCE; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INTERFERON-ALPHA; MODELS, BIOLOGICAL; PHENANTHROLINES; TRANSPLANTATION, AUTOLOGOUS; ZIDOVUDINE;

EID: 0030699177     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199711)56:3<161::AID-AJH5>3.0.CO;2-W     Document Type: Article

References (50)

1. Dunn DT, Newell ML, Mayaux MJ, Kind C, Hutto C, Goedert JJ, Andiman W: Mode of delivery and vertical transmission of HIV-1: A review of prospective studies. Perinatal AIDS collaborative transmission studies. J Acquir Immune Defic Syndr 7:1064-1066, 1994.
2. Peckham CS: Human immunodeficiency virus infection and pregnancy. Sex Transm Dis 21 (Suppl 2): S28-31, 1994.
3. Connor EM, Sperling RS, Gelber R: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331:1173-1180, 1994.
4. Hervas Laguna MJ, Nieto-Rodriguez JA, Geijo-Martinez MP, Ruiz- Ribo MD, Borregson S: Progressive multifocal leukoencephalopathy and AIDS. Response to cytarabine. Ann Med Intern 11:241-243, 1994.
5. Mansberg R, Rowlings PA, Yip MY, Rozenberg MC: First and second remissions in an HIV positive patient following remission and induction therapy for acute non-lymphoblastic leukemia. Aus N Z J MED 21:55-57, 1991.
6. Machida H, Ashida N, Ikeda T, Sakata S, Baba M, Shigeta S: In vitro drug combination of l-beta-D-arabinofuranosyl-E-5-(2-bromoninyl) uracil with anti-human immunodeficiency virus or anticancer nucleosides. Antimicrob Agents Chemother 36:214-216, 1992.
7. Chen CH, Vazquez Padua M, Cheng YC: Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol 39:625-628, 1991.
8. Lane HC, Davey V, Kovacs JA, Feinberg J, Metcalf JA, Herpin B, Walker R, Deyton L, Davey RT, Falloon J: Interferon-alpha in patients with asymptomatic HIV infection. A randomized, placebo-controlled trial. National Institute of Health, Bethesda, D. Ann Intern Med 112: 805-811, 1990.
9. Babiuch L, Mian M, Kaminaska E, Szymanska B, Georgiades JA: An interim report on the effect of natural human interferon alpha (IFN- alpha) lozenges in patients seropositive for the human immunodeficiency virus type 1 (HIV-1). Arch Immunol Ther Exp Warsz 41:213- 319, 1993.
10. Rivero J, Limonta M, Aguilera A, Fraga M, Lopez-Saura P: Use of recombinant Interferon-α in HIV-infected individuals. Biotherapy 8:23-31, 1994.
11. Rozenhuum W, Gharakhanian S, Navarette MS, De-Sahb R, Cardon B, Rouzioux C: Long-term follow-up of 120 patients with AIDS-related Kaposi's sarcoma treated with interteron alpha-2a. J Inv Dermatol 95 (Suppl 6):161S-165S, 1990.
12. Krown SE, Paredes J, Bundow D, Polsky B, Gold JW, Flomenberg N: Interferon-α, zidovudine, and granulocyte-macrophage colony- stimulating factor: A phase I AIDS clinical trials group study in patients with Kaposi's sarcoma associated with AIDS. J Clin Oncol 10:1344-1351, 1992.
13. Contu L, La-Nasa G, Arras M, Pizzati A, Carcassi C, Ledda A, Boero R, Orru S, Pintus A: Allogeneic BMT combined with multiple anti- HIV treatment in cases of AIDS. BMT 12:669-671, 1993.
14. Ammann AJ, Abrams D, Conant M: Acquired immune dysfunction in homosexual men: Immunologic profiles. Clin Immunol Immunopathol 27:315-325, 1983.
15. Klatzmann D, Barre-Sinoussi F, Nugeyre MT: Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 225:59-63, 1984.
16. Dalgleish AG, Beverly PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA: The CD4 antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-767, 1984.
17. Klatzmann DE, Champagne E, Chamaret S: T-lymphocyte T4 molecule behaves as a receptor for human retrovirus LAV (letter). Nature 312:767-768, 1984.
18. Ho DD, Rota TR, Hirsch MS: Infection of monocyte/macrophages by human T lymphotropic virus type III. J Clin Invest 77:1712-1715, 1986.
19. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M: The role of mononuclear phagocytes in HTLV III/LAV infection. Science 233:215-219, 1986.
20. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348, 1986.
21. Montagnier L, Gruest J, Chamaret S: Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science 225:63-66, 1986.
22. Salahuddin SZ, Ablashi DV, Hunter EA: HTLV-III infection of EBV- genome-positive B lymphoid cells with or without detectable T4 antigens. Int J Cancer 39:198-202, 1987.
23. Saral R, Holland HK: Bone marrow transplantation for the acquired immune deficiency syndrome. In: Forman SJ, Blume KG, Thomas ED (eds); "Bone Marrow Transplantation," Ed 1. Blackwell Scientific Publications, Boston 1994, pp 654-664.
24. Ricordi C, Tzakis AG, Rybka WB, Fontes P, Ball ED, Trucco M, Kocova M, Triulzi D, McMichael J, Doyle H: Xenotransplantation of hematopoietic cells resistant to HIV as a potential treatment for patients with AIDS. Transplant Proc 26:1302-1303, 1994.
25. Turner ML, Watson HG, Russel L, Langlands K, Ludlam CA, Parker AC: An HIV positive haemophiliac with acute lymphoblastic leukemia successfully treated with intensive chemotherapy and syngeneic bone marrow transplantation. BMT 9:387-389, 1992.
26. Davis BR, Schwartz DH, Marx JC: Absent or rare HIV infection of bone marrow stem/progenitor cells in vivo. J Virol 65:1985-1990, 1991.
27. von-Laer D, Hufert FT, Fenner TE: CD34+ Hematopoietic progenitor cells are not a major reservoir of the human HIV virus. Blood 76:1281-1286, 1990.
28. Wagner JE, Broxmeyer HE, Rebecca LB, Zehnbauer B, Schmeckpeper B, Shah N, Griffin C, Emanuel PD, Zuckerman KS, Cooper S, Carow C, Bias W, Santos GW: Transplantation of umbilical cord blood after myeloablative therapy: Analysis of engraftment. Blood 79:1874-1881, 1992.
29. Gluckman E, Wagner J, Hows J, Kernan N, Bradley B, Broxmeyer HE: Cord blood banking for hematopoietic stem cell transplantation: An international cord blood transplant registry. BMT 11:199-200, 1993.
30. Wagner JE: Umbilical cord blood stem cell transplantation. Am J Pediatr Hematol Oncol 15:169-174, 1993.
31. Varadi G, Elchalal U, Shushman A, Schenker JG, Nagler A: Human umbilical cord blood as a source of transplantable hematopoietic progenitor cells. Obstet Gynecol Surv 50:611-617, 1995.
32. Apperley JF: Umbilical cord blood progenitor cell transplantation. BMT 14:187-196, 1994.
33. Lansdorp PM, Dragowska W, Mayani H: Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178:787-791, 1993.
34. Lu L, Xiao M, Shen RM, Grigsby S, Broxmeyer HE: Enrichment, characterization and responsiveness of single primitive CD34+ human umbilical cord blood hematopoietic progenitors with high proliferative and relapsing potential. Blood 81:41-48, 1993.
35. Nagler A, Peacock M, Tantoco A, Lamons D, Okarma TB, Okrongly DA: Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection. Exp Hematol 22:1134-1140, 1994.
36. Deutsch VR, Oison TA, Nagler A, Slavin S, Levine RF: The response of cord blood megakaryocyte to IL-3, IL-6, and aplastic canine serum varies with gestational age. Br J Haematol 89:8-16, 1995.
37. Pettengell R, Luft T, Henschler R, Hows JM, Dexter TM, Ryder D, Testa NG: Direct comparison by limiting dilution analysis of long- term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. Blood 84:3653-3659, 1994.
38. Bruyn C. De, Delforge A, Bron D, Ley P, de Hemptinne D, Stryckmans P: Modulation of human cord blood progenitor cell growth by recombinant human IL-3, IL-6, GM-CSF and SCF in serum- supplemented and serum-free medium. Stem Cells 12:616-625, 1994.
39. Moritz T, Keller DC, Williams DA: Human cord blood cells as targets for gene transfer. Potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med 178:529-537, 1993.
40. Lu L, Xiao M, Clapp DW, Li ZH, Broxmeyer HE: High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34+ hematopietic stem/progenitor cells from human umbilical cord blood. J Exp Med 178:2089-2095, 1993.
41. Lu L, Xiao M, Clapp DW, Li ZH, Broxmeyer HE: Stable integration of retrovirally transduced genes into human umbilical cord blood high- proliferative potential colony forming cells (HPP-CFC) as assessed after multiple HPP-CFC colony replating in vivo. Blood Cells 20:525- 533, 1994.
42. Zhou SZ, Cooper S, Kang LY, Ruggieri L, Heunfeld S, Srivastava A, Broxmeyer HE: Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 179:186-192, 1994.
43. Lu L, Yue G, Li ZH, Freie B, Clapp DW, Broxmeyer HE: CD 34+ stem-progenitor cells purified from cryoperserved normal cord blood can be transduced with high efficiency by a retroviral vector and expanded ex vivo with stable integration and expression of Fanconi anemia coplernentation C gene. Cell Transplant 4:493-498, 1995.
44. Lu Li, Ge Yue, Li Zhi-Hua, Keeble W, Kabat D, Bagby GC, Broxmeyer HE, Hoatin ME: Retroviral transfer of the recombinant human erythropoietin receptor into single hematopoietic stem/progenitor cells from human cord blood increases the number of erythropoietin- dependent erythroid colonies. Blood 87:525-534, 1996.
45. Rice A, Barbot C, Lacombe F, Dubosc-Marchenary N, Mark G, Hau F, Boiron JM, Reiffers J: 5-fluoracil permits access to a primitive subpopulation of peripheral blood stem cells. Stem Cells 11:326-335, 1993.
46. Koistine P, Wang C, Curtis JE, McCulloch EA: GM-CSF and IL-3 protect leukemic blast cells from Ara-C toxicity. Leukemia 9:789-795, 1991.
47. Nagler A, Mumcuoglu M, Naparstek E, Or R, Gan S, Slavin S: Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth. Leuk Res 17:61-67, 1993.
48. Hagenbeck A, Martens AC: Toxicity of ASTA-Z 7557 (mafosfamide) to normal and leukemic stem cells: Implications for autologous bone marrow transplantation. Invest New Drugs 2:237-243, 1984.
49. Shochet NR, Rudi A, Kashman Y, Hod Y, Raffat El-Maghrabi M, Spector I: Novel marine alkaloids from the Tunicate Eudistoma sp. are potent regulators of cellular growth and differentiation and affect cAMP-mediated processes. J Cell Physiol 157:481-492, 1993.
50. Einat M, Lishner M, Amiel A, Nagler A, Golde DW, Yarkoni S, Rudi A, Kashman Y, Markel D, Fabian I: Eilatin: A novel marine alkaloid inhibits in vitro proliferation of progenitor cells of chronic myeloid leukemia patients. Exp Hematol 23:1439-1444, 1995.